Patent details
EP1871347 Title: PHARMACEUTICAL COMPOSITION
Basic Information
- Publication number:
- EP1871347
- PCT Application Number:
- PCT/US/2006/014447
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067504753
- PCT Publication Number:
- WO/2006/113649
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION
- French Title of Invention:
- PREPARATION PHARMACEUTIQUE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNG
- SPC Number:
Dates
- Filing date:
- 18/04/2006
- Grant date:
- 03/08/2016
- EP Publication Date:
- 03/08/2016
- PCT Publication Date:
- 26/10/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/01/2008
- EP B1 Publication Date:
- 03/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/04/2021
- Expiration date:
- 18/04/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/04/2006
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- CAMPBELL Dwayne A., GlaxoSmithKline Corp. Int.
- Address:
- United States (US)
2
- Name:
- CARTER Barry Howard, GlaxoSmithKline Corp. Int.
- Address:
- United States (US)
Priority
- Priority Number:
- 672805 P
- Priority Date:
- 19/04/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/20;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/04/2020
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 213 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|